Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Hum Exp Toxicol ; 33(1): 54-63, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23536518

RESUMEN

It has been hypothesized that oils containing high levels of omega-3 polyunsaturated fatty acids, such as canola and fish oil, could counteract some of the adverse effects induced by phthalates. In the present study, the influence of different oily vehicles on di-butyl phthalate (DBP)-induced testicular toxicity and lipid profile was investigated. Pregnant Wistar rats were treated by oral gavage from gestation days 13 to 20 with DBP (500 mg/kg/day) diluted in three different vehicles: corn, canola or fish oil. Male fetuses were analyzed on gestation day 20. DBP exposure lowered intratesticular testosterone levels and anogenital distance, regardless of the vehicle used. The percentage of seminiferous cords containing multinucleated gonocytes and cord diameter was increased in DBP-exposed groups, compared with vehicle controls, with no difference between the three DBP-exposed groups. Clustering of Leydig cells was seen in all DBP groups. Lipid profile indicated that administration of canola and fish oil can increase the content of omega-3 fatty acids in rat testis. However, content of omega-3 was diminished in DBP-treated groups. Overall, our results indicate that different oily vehicles did not alter fetal rat testicular toxicity induced by a high DBP dose.


Asunto(s)
Dibutil Ftalato/toxicidad , Disruptores Endocrinos/toxicidad , Ácidos Grasos Omega-3/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Exposición Materna/efectos adversos , Vehículos Farmacéuticos/metabolismo , Testículo/efectos de los fármacos , Animales , Aceite de Maíz/química , Aceite de Maíz/metabolismo , Dibutil Ftalato/administración & dosificación , Disruptores Endocrinos/administración & dosificación , Contaminantes Ambientales/administración & dosificación , Contaminantes Ambientales/toxicidad , Ácidos Grasos Monoinsaturados/química , Ácidos Grasos Monoinsaturados/metabolismo , Ácidos Grasos Omega-3/química , Femenino , Desarrollo Fetal/efectos de los fármacos , Aceites de Pescado/química , Aceites de Pescado/metabolismo , Masculino , Vehículos Farmacéuticos/química , Plastificantes/administración & dosificación , Plastificantes/toxicidad , Embarazo , Aceite de Brassica napus , Ratas , Procesos de Determinación del Sexo/efectos de los fármacos , Testículo/embriología , Testículo/metabolismo , Testosterona/metabolismo
2.
Hum Exp Toxicol ; 32(9): 930-41, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23424214

RESUMEN

Artemisinins combination therapy (ACT) is the first choice therapy for falciparum malaria. Data on the safety of ACTs in pregnancy are limited and controversial and the use is not recommended on the first trimester. To evaluate the effects of isolated and combined artesunate (AS)/mefloquine (MQ) on embryo rats, pregnant rats were treated orally with AS (15 and 40 mg/kg body weight (bwt)/day), MQ (30 and 80 mg/kg bwt/day) and AS/MQ (15/30 and 40/80 mg/kg bwt/day) on days 9-11 post coitum (pc). The dams were euthanized on day 12 pc and gestational and embryos histological parameters were evaluated. Embryolethality and histopathological anomalies were significant when AS was given alone or combined with MQ. Combination of AS and MQ did not enhance their toxicity compared to their separate administrations; on the other side, there was a reduction in the toxic effects of the AS when combined with MQ. Isolated MQ did not induce developmental toxicity.


Asunto(s)
Antimaláricos/toxicidad , Artemisininas/toxicidad , Embrión de Mamíferos/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Exposición Materna/efectos adversos , Mefloquina/toxicidad , Animales , Antimaláricos/administración & dosificación , Artemisininas/administración & dosificación , Artesunato , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Pérdida del Embrión/inducido químicamente , Pérdida del Embrión/metabolismo , Pérdida del Embrión/patología , Embrión de Mamíferos/metabolismo , Embrión de Mamíferos/patología , Femenino , Mefloquina/administración & dosificación , Embarazo , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA